Closed Solicitation · DEPARTMENT OF HEALTH AND HUMAN SERVICES

    TECHNICAL CONSULTING SERVICES AND DATA ANALYSIS OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUES AS A NOVEL PHARMACOTHERAPEUTIC APPROACH FOR ALCOHOL USE DISORDER (AUD)

    Sol. 75N95023Q00552Combined Synopsis/SolicitationBethesda, MD
    Closed
    STATUS
    Closed
    closed Aug 23, 2023
    POSTED
    Aug 16, 2023
    Publication date
    NAICS CODE
    541715
    Primary industry classification
    PSC CODE
    Product & service classification

    AI Summary

    The National Institutes of Health is seeking technical consulting services and data analysis related to glucagon-like peptide-1 analogues for addressing alcohol use disorder. This opportunity is a combined synopsis/solicitation under FAR Subpart 12.6, focusing on commercial services. Interested bidders should prepare to submit proposals in response to this RFP.

    Contract details

    Solicitation No.
    75N95023Q00552
    Notice Type
    Combined Synopsis/Solicitation
    Posted Date
    August 16, 2023
    Response Deadline
    August 23, 2023
    NAICS Code
    541715AI guide
    State
    MD
    ZIP Code
    20892
    AI Product/Service
    service

    Description

     (i)        This is a combined synopsis/solicitation for a commercial service in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 as supplemented with additional information in

    Key dates

    1. August 16, 2023Posted Date
    2. August 23, 2023Proposals / Responses Due

    AI search tags

    Frequently asked questions

    TECHNICAL CONSULTING SERVICES AND DATA ANALYSIS OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUES AS A NOVEL PHARMACOTHERAPEUTIC APPROACH FOR ALCOHOL USE DISORDER (AUD) is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.

    SamSearch Platform

    Stop searching. Start winning.

    AI-powered intelligence for the right opportunities, the right leads, and the right time.